Analysis of Beijing Balance Medical Secures NMPA Nod for Renatus Transcatheter Aortic Valve System - aVenture Research
Insight, China's Pharmaceutical Industry
Beijing Balance Medical Secures NMPA Nod for Renatus Transcatheter Aortic Valve System
Beijing Balance Medical Technology Co., Ltd (SHA: 688198) has received market approval from the National Medical Products Administration (NMPA) for its Renatus transcatheter aortic valve system. This in-house developed product is now approved for use in patients aged 70 years or older who are diagnosed with symptomatic, calcified, and severe degenerative aortic valve stenosis and are not candidates for routine surgical valve replacement after a comprehensive evaluation by the cardiac team and sc
An analysis reads this article and its sources, then explains what happened, who is involved, and what it means, quoting a source for each claim. Once written, every reader sees it here.
Analysis requires a paid plan or prepaid credits and uses your company research allowance.